- Home
- / Lepu Biopharma
Lepu Biopharma
Stock Price
$5.8
2023-05-22
Market Capitalization
$9.4 B
2023-05-22
Revenue
¥15.6 M
FY, 2022
Lepu Biopharma Summary
Company summary
- Overview
- Lepu Biopharma is a biopharmaceutical company that focuses on oncology therapeutics. It develops a pipeline of drug candidates including ADCs, oncolytic virus drugs, and immunotherapies at clinical and pre-clinical stages.
- Type
- Public
- Status
- Active
- Founded
- 2018
- HQ
- HK | view all locations
Lepu Biopharma Financials
Summary financials
- Revenue (FY, 2022)
- ¥15.6M
- Gross profit (FY, 2022)
- ¥24.7M
- Net income (FY, 2022)
- (¥699.4M)
- Cash (FY, 2022)
- ¥669.4M
- EBIT (FY, 2022)
- (¥673.9M)
- Enterprise value
- $9.4B
News
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension